Home
Product Name | T0070907 |
Price: | Inquiry |
Catalog No.: | CN00422 |
CAS No.: | 313516-66-4 |
Molecular Formula: | C12H8ClN3O3 |
Molecular Weight: | 277.66 g/mol |
Purity: | >=98% |
Type of Compound: | Alkaloids |
Physical Desc.: | Powder |
Source: | |
Solvent: | Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc. |
SMILES: | Clc1ccc(cc1C(=O)Nc1ccncc1)[N+](=O)[O-] |
Contact us | |
---|---|
First Name: | |
Last Name: | |
E-mail: | |
Question: | |
Description | T0070907 is a potent PPARγ antagonist with a Ki of 1 nM. |
Target | PPARγ:1 nM (Ki) PPARδ:1.8 μM (Ki) PPARα:0.85 μM (Ki) |
In Vitro | T0070907 (50 μM) pre-treatment impairs repair of IR-induced DNA DSBs in both ME-180 and SiHa cells treated with irradiated (4 Gy). T0070907 (0-50 μM) significantly decreases the levels of DNA-PKcs and RAD51 proteins in ME-180 and SiHa cells[1]. T0070907 (50 μM) treatment reduces the levels of α- and β-tubulin protein in a time-dependent manner, decreases the synthesis of DNA, and prevents the radiation-induced alterations in the cell cycle regulatory proteins of ME180 and SiHa cells[2]. T0070907 (10 µM) has cytotoxicity in an adipocyte-specific and PPARγ-independent manner. T0070907 increases oxidative stress in immature adipocytes[3]. T0070907 (1 μM) blocks the induction of adipogenesis by various treatments of the adipogenic cell line 3T3-L1. T0070907 covalently modifies PPAR on cysteine 313 in helix 3 of human PPAR 2[4]. |
Density | 1.5±0.1 g/cm3 |
Boiling Point | 381.7±37.0 °C at 760 mmHg |
Flash Point | 184.6±26.5 °C |
Exact Mass | 277.025421 |
PSA | 87.81000 |
LogP | 2.25 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Storage condition | Store at RT |